Menu
  • VEDS
    • What is Vascular Ehlers-Danlos Syndrome?
    • What are the signs?
    • Is Vascular Ehlers-Danlos Syndrome Inherited?
    • How is the body affected?
  • What to Expect
    • Diagnosis
    • Emergency Situations
    • Emergency Preparedness
    • Treatment and Management
      • Medications
      • Imaging
      • Maintaining Healthy Bowel Habits
      • Circumstances to Avoid
      • Developing Your Care Team
    • Pregnancy
  • Resources
    • Ask a Question
    • Find a Doctor
    • Webinars
    • Virtual Support Groups
    • Parent Toolkit
      • School Safety
      • Your Child’s Doctor and Healthcare
      • Sydney Lerman Hospitality Program
      • Resources and Support
    • Past Conference Recordings
    • For Health Professionals
      • Management Resources
      • Publications
      • Contact a VEDS Expert
      • Continuing Medical Education (CME)
      • Grand Rounds
      • Information for the Emergency Department
    • Emergency Preparedness
    • Free Medical IDs for Individuals with VEDS 
  • Events
    • Conference
    • Symposiums
    • Marfan Foundation Walk for Victory
    • Camps for Kids and Families
    • VEDS Action Month
    • The Marfan Foundation Events
  • Research
    • For Researchers
      • Research Grants
      • Find Study Participants
      • VEDS Scientific Meeting
    • For Patients
      • Participate in a Research Study
      • Current Research Studies
    • VEDS Collaborative
  • Volunteer
    • VEDS Awareness Team
    • Speaker Series: Grand Rounds Team
    • Social Media Awareness Team
    • Legislative Ambassadors
    • School Nurse Champions
    • Community Action Team
    • Event Volunteers
    • Writing Group
  • Community Corner
    • Community Stories
    • Share Your Story
  • About Us
    • The VEDS Movement
    • How We Help
    • Leadership
    • News
    • Annual Report and Financials
    • Contact Us
  • Donate

Medications

Common Medications in Vascular Ehlers-Danlos Syndrome

Controlling Blood Pressure

blood pressure cuff

Blood pressure monitoring on a regular basis is recommended to allow for early treatment if hypertension develops, thus reducing the risk for vascular stress and injury.  Physicians may suggest use of blood pressure medications to patients with Vascular Ehlers-Danlos Syndrome (VEDS) even if the blood pressure is not high to try to minimize baseline vascular stress and influence the integrity of the blood vessel wall. Affected individuals should follow their doctors’ recommendations for taking medications. In general, blood pressure medications should not be stopped abruptly as this can cause a sudden and severe risk in hemodynamic stress (pressure on the blood vessels). Methods to wean off these medications should be discussed with personal physicians. 

  • Beta blockers, (also known as beta-adrenergic blocking agents), are medications that cause your heart to beat more slowly and with less force, which lowers blood pressure. Beta blockers can also lower blood pressure by reducing the resistance in your arteries. Currently, there is no expert consensus or trial evidence supporting the routine use of beta-blockers or the selection among various drugs within this class. Typical beta-blockers that are prescribed for individuals with VEDS are atenolol, metoprolol, propranolol and others. It is important to take blood pressure medication as prescribed to assure that blood pressure is maintained in the normal range.
  • Angiotension Receptor Blockers (ARBs) are another class of drugs known to control blood pressure but work differently from beta-blockers.  As with beta-blockers, at this time, the benefit or risks of this class of drug remains unknown for individual with VEDS. Cozaar (losartan), Avapro (irbesartan) and Benicar (olmesartan) are typical ARBs.
  • Celiprolol is a third-generation beta-blocker only available in Europe.  Acer Therapeutics recently requested that the FDA approve celiprolol for use in people with VEDS, based on a combination of the results in a small trial and data on long-term safety and outcome in a natural history study.  The FDA rejected their request based on limitations in the data available. Patients should be aware that there are similar third generation beta-blockers, such as carvedilol, nebivolol, and labetalol, available in the US that are being prescribed off-label for this condition. However, there are no trials or long-term studies utilizing these drugs investigating protective effects or safety in this population. See The Marfan Foundation official statement on the FDA rejection of celiprolol.

Bowel Regularity

Many individuals with VEDS benefit from stool softeners and a regular laxative regimen. It is generally suggested to use bulk laxatives that draw fluid into the bowel, but to avoid stimulant laxatives that stimulate the bowel to contract. See more about maintaining healthy bowel habits.

Other Medications for Vascular Ehlers-Danlos Syndrome

Sliced oranges

Many physicians suggest routine use of high-dose vitamin C, which can help the body make better use of the collagen that it has available. Generally, a dose of 2-3 grams per day is considered for adults with VEDS. Pediatric dosing is individualized based on age and size. This should be discussed with personal physicians.

Search Our Site

Go to…

  • Diagnosis
  • Emergency Situations
  • Emergency Preparedness
  • Treatment and Management
    • Medications
    • Imaging
    • Maintaining Healthy Bowel Habits
    • Circumstances to Avoid
    • Developing Your Care Team
  • Pregnancy

The VEDS Movement, a division of
The Marfan Foundation, is a qualified 501(c)(3) tax-exempt organization. EIN: 52-1265361
| Privacy Statement

Information for the Emergency Department

Search Our Site
Contact Us

22 Manhasset Avenue, Port Washington, NY 11050

800.862.7326

Copyright 2022. All rights reserved
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}